NEW YORK CITY & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Silence Therapeutics plc (NasdaqGM: SLN) to Merck KGaA, Darmstadt, Germany. Under the terms of the proposed transaction, shareholders of Silence will receive $20.00 in cash for each share of Silence that they own. KSF is seeking to determine whether this consideration and the process that led to